2-Aminoethoxydiphenylborane Is an Acute Inhibitor of Directly Photosensitive Retinal Ganglion Cell Activity in Vitro and in Vivo
Total Page:16
File Type:pdf, Size:1020Kb
The Journal of Neuroscience, April 11, 2007 • 27(15):3981–3086 • 3981 Brief Communications 2-Aminoethoxydiphenylborane Is an Acute Inhibitor of Directly Photosensitive Retinal Ganglion Cell Activity In Vitro and In Vivo Sumathi Sekaran,1 Gurprit S. Lall,2 Katherine L. Ralphs,3 Adrian J. Wolstenholme,3 Robert J. Lucas,2 Russell G. Foster,1 and Mark W. Hankins1 1Circadian and Visual Neuroscience Group, University of Oxford, Wellcome Trust Centre for Human Genetics, Oxford OX3 7BN, United Kingdom, 2Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom, and 3Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, United Kingdom The mammalian retina contains directly photosensitive retinal ganglion cells (RGCs), which use the photopigment melanopsin. The generation of mice lacking melanopsin has been invaluable in elucidating the function of these cells. These animals display deficiencies in circadian photoentrainment, the pupil light reflex, and the circadian regulation of the cone pathway. Interpreting the results from such gene knock-out models is always complicated by neuronal plasticity and the potential for restructuring of neuronal networks. Until now, the study of photosensitive RGCs has lacked an acute inhibitor. 2-Aminoethoxydiphenylborane (2-APB) is an antagonist at IP3 receptors and an inhibitor of canonical transient receptor potential ion channels (TRPCs). Here, we show that 2-APB is an extremely potent in vitro inhibitor of the photosensitive RGCs and that its effect is independent of store-dependent Ca 2ϩ release. The identification of canonical TRPC6 and TRPC7 ion channels in melanopsin-expressing ganglion cells suggests that 2-APB may act directly on a TRPC ion channel. Importantly, using the pupil light reflex as a functional assay, we show that 2-APB inhibits photosensitive RGC activity in vivo. Collec- tively, our data further elucidate the phototransduction pathway in the photosensitive RGCs and demonstrate that 2-APB can be used to silence activity in these cells both in vitro and in vivo. Key words: 2-aminoethoxydiphenylborane; melanopsin; retinal ganglion cell; TRPC6; TRPC7; pupil light reflex Introduction The full functional implications of the melanopsin-expressing A small subset of mammalian retinal ganglion cells (RGCs) photosensitive RGCs are unclear. The axons of these cells project (1–3%) are directly photosensitive (Berson et al., 2002; Sekaran et to brain regions involved in non-image-forming functions, in- al., 2003). These cells express melanopsin (Hattar et al., 2002), a cluding the suprachiasmatic nucleus and the olivary pretectal G-protein-coupled receptor protein that forms a fully functional nucleus (Hattar et al., 2002). Somewhat surprisingly, they also photopigment in expression systems (Melyan et al., 2005; Panda innervate a wide range of additional targets, including the lateral et al., 2005; Qiu et al., 2005). To assess the function of the photo- geniculate nucleus, the superior colliculus, and the amygdala Ϫ Ϫ sensitive RGCs, mice with a targeted disruption of the melanop- (Hattar et al., 2006). The use of Opn4 / mice will go some way sin gene (Opn4) have been generated (Hattar et al., 2002; Panda to further our understanding of photosensitive RGC outputs, but et al., 2002). Opn4Ϫ/Ϫ mice lack intrinsic light responses of gan- as with all knock-out models, these studies are confounded by glion cell layer neurons (Hattar et al., 2002) and exhibit deficien- possible neuronal restructuring during development. At present, cies in circadian photoentrainment (Panda et al., 2002), the pupil the field lacks an acute inhibitor of photosensitive RGC activity. light reflex (PLR) (Lucas et al., 2003), and circadian regulation of The main aim of the current study was to identify a pharma- the cone pathway (Barnard et al., 2006). These studies have dem- cological agent that could acutely target the photosensitive RGCs. onstrated that this small population of photosensitive RGCs pro- To narrow our search, we focused on canonical transient receptor vides a significant contribution to non-image-forming photic potential (TRP) ion channels (TRPCs), which have been sug- responses. gested to be the likely endpoint in the phototransduction path- way that couples to melanopsin on the basis of several lines of evidence. Melanopsin shows high sequence homology to inver- Received Oct. 30, 2006; revised March 12, 2007; accepted March 14, 2007. ThisworkwassupportedbytheWellcomeTrustandtheBiotechnologyandBiologicalSciencesResearchCouncil. tebrate opsins (Provencio et al., 1998), which can couple to TRP We thank King-Wai Yau and Samer Hattar for the kind gift of the melanopsin knock-out mouse line. ion channels (Montell, 2005). Coexpression of melanopsin with CorrespondenceshouldbeaddressedtoSumathiSekaran,CircadianandVisualNeuroscienceGroup,Universityof TRPC channels resulted in the generation of a functional pho- Oxford, Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford OX3 7BN, UK. E-mail: topigment (Panda et al., 2005; Qiu et al., 2005). Light-evoked [email protected]. DOI:10.1523/JNEUROSCI.4716-06.2007 currents in rat photosensitive RGCs can be suppressed by TRPC Copyright © 2007 Society for Neuroscience 0270-6474/07/273981-06$15.00/0 channel blockers (Warren et al., 2006). The results from the 3982 • J. Neurosci., April 11, 2007 • 27(15):3981–3086 Sekaran et al. • 2-APB Blocks Photosensitive Retinal Ganglion Cells present study provide additional support for a role of TRPC (1:500; all from Alomone Labs, Jerusalem, Israel), or ␣-TRPC7 (1:200) channels in the phototransduction pathway of mouse photosen- (supplemental Fig. 1, available at www.jneurosci.org as supplemental sitive RGCs. In particular, we found that the TRPC channel in- material). All TRPC antibodies were raised in rabbit (secondary anti- body, Alexa Fluor 488 donkey ␣-rabbit IgG). Sections were mounted in hibitor 2-aminoethoxydiphenylborane (2-APB) is a potent in- Ј Ј hibitor of intrinsic light-evoked activity in the ganglion cell layer, media with 4 ,6 -diamidino-2-phenylindole dihydrochloride (DAPI) (Vector Laboratories) and visualized with a Zeiss LSM510 confocal both in vitro and in vivo. microscope. Pupillometry. All measurements were restricted to the middle of the Materials and Methods light portion of a 12 h light/dark cycle. The consensual PLR was recorded All procedures were performed under United Kingdom Home Office from dark-adapted (20 min) C3H mice 70–120 d of age (preinjection guidelines. control) (Lucas et al., 2001). Mice were anesthetized with isoflurane Calcium imaging. Retinas from C3H mice (wild type at the rd locus; before intraocular injection. A glass electrode attached to a Hamilton postnatal days 4–5) and C3H rd/rd cl mice (3–6 months) were placed in syringe was used to inject 1 l of solution containing pharmacological a recording chamber ganglion cell side up and incubated in Ringer’s agents or vehicle control (1% DMSO). Recovery from anesthesia was solution [(in mM) 119 NaCl, 2.5 KCl, 1 KH PO , 1.3 MgCl , 2.5 CaCl , complete within minutes, and postinjection PLR recordings were made 2 4 2 2 ϫ 12 26.2 NaHCO , and 20 D-glucose; equilibrated with 95% O /5% CO ;pH at 20 and 40 min time points. Light stimuli (480 nm; 10 10 photons/ 3 2 2 2 7.4] containing 10 M fura-2 AM (Invitrogen, Paisley, UK). The fluores- cm /s) of 1 min duration were generated using a xenon arc source trans- cent imaging technique has been described in detail previously (Sekaran ferred into an integrating sphere by an optic cable to provide illumina- et al., 2003, 2005). Briefly, the dual-wavelength Ca 2ϩ-sensitive indicator tion to the whole eye. Pupil images were digitally captured using a CCD fura-2 AM was excited alternately at 340 and 380 nm. Emitted fluores- camera and analyzed by software developed in house. After the last pu- ϳ cence (510 nm) was captured with an intensified CCD camera every 2 s. pillary recording, all mice were killed ( 40 min after injection). ϩ Retinas were stimulated at 470 Ϯ 20 nm (4.9 ϫ 10 12–2.9 ϫ 10 15 photons/ Drugs. The following drugs were used: L-( )-2-amino-4- s/cm 2) interleaved between image acquisitions. Pharmacological agents phosphonobutyric acid (L-AP4; Tocris Bioscience, Bristol, UK); DL-2- were administered until two successive light-evoked responses of equiv- amino-5-phosphonopentanoic acid (DL-AP5; Tocris Bioscience); ϩ alent amplitude were obtained (maximum period of drug application 2-aminoethoxydiphenylborane (Tocris Bioscience); ( )-cis-diltiazem was 30 min). The drift in the baseline fluorescence was corrected to the hydrochloride (L-cis-diltiazem; Sigma); cyclopiazonic acid (Tocris Bio- prestimulus values (⌬F/F) by curve fitting. The integrated change in science); 6,7-dinitroquinoxaline-2,3-dione (DNQX; Tocris Bioscience); fluorescence during light stimulation was calculated (F/s 2). Where pos- flufenamic acid (Sigma); SKF96365 hydrochloride (Tocris Bioscience); sible, responses from two repeated stimulations were averaged for the and thapsigargin (Tocris Bioscience). control and drug-treated conditions. Data are expressed as mean Ϯ SEM, and statistical analysis was performed with paired t tests. Results TRPC7 antibody generation and validation. The TRPC7 antibody was Effect of TRPC channel inhibitors on the photosensitive RGC raised against a peptide corresponding to the C-terminal 16 aa of human light response in vitro TRPC7 (hTRPC7) coupled to keyhole limpet hemocyanin using 0.05% To visualize the light responses